Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 207495
Company: AMNEAL PHARMS
Company: AMNEAL PHARMS
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
IMATINIB MESYLATE | IMATINIB MESYLATE | EQ 100MG BASE | TABLET;ORAL | Discontinued | None | No | No |
IMATINIB MESYLATE | IMATINIB MESYLATE | EQ 400MG BASE | TABLET;ORAL | Discontinued | None | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
02/08/2019 | ORIG-1 | Approval | STANDARD |
Label is not available on this site. |
Supplements
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
---|---|---|---|---|---|
09/25/2023 | SUPPL-3 | Labeling-Package Insert |
Label is not available on this site. |
||
09/25/2023 | SUPPL-2 | Labeling-Package Insert, Labeling-Container/Carton Labels |
Label is not available on this site. |
||
09/25/2023 | SUPPL-1 | Labeling-Package Insert |
Label is not available on this site. |